Canada Biotechnology Market Size & Outlook, 2024-2030
Canada Biotechnology Market, 2018-2030 (US$M)
Global Market
Related Markets
Canada biotechnology market highlights
- The Canada biotechnology market generated a revenue of USD 90,373.6 million in 2023 and is expected to reach USD 206,813.8 million by 2030.
- The Canada market is expected to grow at a CAGR of 12.6% from 2024 to 2030.
- In terms of segment, health was the largest revenue generating application in 2023.
- Bioinformatics is the most lucrative application segment registering the fastest growth during the forecast period.
Biotechnology market data book summary
| Market revenue in 2023 | USD 90,373.6 million |
| Market revenue in 2030 | USD 206,813.8 million |
| Growth rate | 12.6% (CAGR from 2023 to 2030) |
| Largest segment | Health |
| Fastest growing segment | Bioinformatics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Health, Food & Agriculture, Natural reseources & Environment, Industrial Processing, Bioinformatics, Others Applications |
| Key market players worldwide | AstraZeneca PLC, Gilead Sciences Inc, Bristol-Myers Squibb Co, Sanofi SA, Biogen Inc, Abbott Laboratories, Pfizer Inc, Amgen Inc, Novo Nordisk A/S ADR, Merck KGaA, Johnson & Johnson, Novartis AG ADR, Roche Holding AG, Lonza Group Ltd |
Other key industry trends
- In terms of revenue, Canada accounted for 5.8% of the global biotechnology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biotechnology market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 206,813.8 million by 2030.
Canada is recognized for its advanced healthcare and life sciences solutions. The country is home to highly skilled and experienced life sciences professionals. It hosts an innovative environment for the life sciences industry, with broad research networks, abundant partnership opportunities, first-rate academic institutions, and lower costs.
The biotechnology market in Canada is expected to register significant growth throughout he forecast period owing to the ongoing advancements by institutions such as the Ontario University for development of molecular and companion diagnostics using applications of next-generation sequencing.
Furthermore, technological advancements in applications such as noninvasive prenatal testing and large-scale population sequencing projects are also expected to drive demand through to 2030. The capital raised by Canadian biotechnology companies has increased significantly in recent years.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biotechnology Market Scope
Biotechnology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Amgen Inc | View profile | 26,700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | www.amgen.com |
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Bristol-Myers Squibb Co | View profile | 34,100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | www.bms.com |
Canada Biotechnology Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biotechnology Market Outlook will help companies and investors design strategic landscapes.
Health was the largest segment with a revenue share of 44.06% in 2023.
Horizon Databook has segmented the Canada biotechnology market based on health, food & agriculture, natural reseources & environment, industrial processing, bioinformatics, others applications covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is recognized for its advanced healthcare and life sciences solutions. The country is home to highly skilled and experienced life sciences professionals. It hosts an innovative environment for the life sciences industry, with broad research networks, abundant partnership opportunities, first-rate academic institutions, and lower costs.
The biotechnology market in Canada is expected to register significant growth throughout he forecast period owing to the ongoing advancements by institutions such as the Ontario University for development of molecular and companion diagnostics using applications of next-generation sequencing.
Furthermore, technological advancements in applications such as noninvasive prenatal testing and large-scale population sequencing projects are also expected to drive demand through to 2030. The capital raised by Canadian biotechnology companies has increased significantly in recent years.
- Canada Biotechnology Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Fermentation
- Chromatography Market
- DNA Sequencing
- Cell Based Assay
- Others
- PCR Technology
- Nanobiotechnology
- Tissue engineering and Regeneration
- Canada Biotechnology Market Application Outlook (Revenue, USD Million , 2018-2030)
- Natural reseources & Environment
- Others Applications
- Food & Agriculture
- Health
- Industrial Processing
- Bioinformatics
Reasons to subscribe to Biotechnology Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biotechnology Market Outlook databook
- Our clientele includes a mix of Biotechnology Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada Biotechnology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Canada Biotechnology Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Canada Biotechnology Market, 2018-2030 (US$M)
Canada biotechnology market statistics, by technology, 2018-2030 (US$M)
